Home/Filings/4/0001437749-19-006477
4//SEC Filing

Wrighton-Smith Peter 4

Accession 0001437749-19-006477

CIK 0001586049other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 4:30 PM ET

Size

10.9 KB

Accession

0001437749-19-006477

Insider Transaction Report

Form 4
Period: 2019-04-01
Wrighton-Smith Peter
DirectorChief Executive Officer
Transactions
  • Sale

    Ordinary Shares

    2019-04-01$17.21/sh600$10,326434,538 total
  • Award

    Share Option (Right to Buy)

    2019-04-01+67,95967,959 total
    Exercise: $16.42Exp: 2029-04-01Ordinary Shares (67,959 underlying)
  • Award

    Ordinary Shares

    2019-04-01+31,669445,138 total
  • Sale

    Ordinary Shares

    2019-04-01$16.64/sh10,000$166,446435,138 total
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2015, as amended.
  • [F2]The price reported for the sales on April 1, 2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.25 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
  • [F3]The price reported for the sales on April 1, 2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.20 to $17.25 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
  • [F4]Options granted under Issuer's 2013 Share Incentive Plan
  • [F5]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2020 through January 1, 2023.

Issuer

Oxford Immunotec Global PLC

CIK 0001586049

Entity typeother

Related Parties

1
  • filerCIK 0001592286

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:30 PM ET
Size
10.9 KB